Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients

被引：34
|
作者：
Reardon, David A.
Nayak, Lakshmi
Peters, Katherine B.
Clarke, Jennifer Leigh
Jordan, Justin T.
De Groot, John Frederick
Nghiemphu, Phioanh Leia
Kaley, Thomas Joseph
Colman, Howard
Gaffey, Sarah C.
Caruso, Victoria
Debruyne, Myriam Bednarek
Bhavsar, Chinmay
Molinaro, Annette M.
Smith, Timothy
Severgnini, Mariano
Wen, Patrick Y.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA USA
[5] Massachusetts Gen Hosp, Boston, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Neuro Oncol, Houston, TX USA
[7] Univ Calif Los Angeles, Los Angeles, CA USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Hunstman Canc Inst, Salt Lake City, UT USA
[10] Harvard Med Sch, Dana Farber, Brigham & Womens Canc Ctr, Boston, MA USA
[11] UC San Francisco, San Francisco, CA USA
[12] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2006
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
    Nassiri, Farshad
    Patil, Vikas
    Yefet, Leeor S.
    Singh, Olivia
    Liu, Jeff
    Dang, Rachel M. A.
    Yamaguchi, Takafumi N.
    Daras, Mariza
    Cloughesy, Timothy F.
    Colman, Howard
    Kumthekar, Priya U.
    Chen, Clark C.
    Aiken, Robert
    Groves, Morris D.
    Ong, Shirley S.
    Ramakrishna, Rohan
    Vogelbaum, Michael A.
    Khagi, Simon
    Kaley, Thomas
    Melear, Jason M.
    Peereboom, David M.
    Rodriguez, Analiz
    Yankelevich, Maxim
    Nair, Suresh G.
    Puduvalli, Vinay K.
    Aldape, Kenneth
    Gao, Andrew
    Lopez-Janeiro, Alvaro
    de Andrea, Carlos E.
    Alonso, Marta M.
    Boutros, Paul
    Robbins, Joan
    Mason, Warren P.
    Sonabend, Adam M.
    Stupp, Roger
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Lang, Frederick F.
    Zadeh, Gelareh
    NATURE MEDICINE, 2023, 29 (06) : 1370 - +
  • [32] Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
    Farshad Nassiri
    Vikas Patil
    Leeor S. Yefet
    Olivia Singh
    Jeff Liu
    Rachel M. A. Dang
    Takafumi N. Yamaguchi
    Mariza Daras
    Timothy F. Cloughesy
    Howard Colman
    Priya U. Kumthekar
    Clark C. Chen
    Robert Aiken
    Morris D. Groves
    Shirley S. Ong
    Rohan Ramakrishna
    Michael A. Vogelbaum
    Simon Khagi
    Thomas Kaley
    Jason M. Melear
    David M. Peereboom
    Analiz Rodriguez
    Maxim Yankelevich
    Suresh G. Nair
    Vinay K. Puduvalli
    Kenneth Aldape
    Andrew Gao
    Álvaro López-Janeiro
    Carlos E. de Andrea
    Marta M. Alonso
    Paul Boutros
    Joan Robbins
    Warren P. Mason
    Adam M. Sonabend
    Roger Stupp
    Juan Fueyo
    Candelaria Gomez-Manzano
    Frederick F. Lang
    Gelareh Zadeh
    Nature Medicine, 2023, 29 : 1370 - 1378
  • [33] ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL
    Nassiri, Farshad
    Patil, Vikas
    Yefet, Leeor
    Singh, Olivia
    Liu, Jeff
    Dang, Rachel
    Yamaguchi, Takafumi
    Daras, Mariza
    Cloughesy, Timothy
    Colman, Howard
    Kumthekar, Priya
    Chen, Clark
    Aiken, Robert
    Groves, Morris
    Ong, Shirley
    Ramakrishna, Rohan
    Vogelbaum, Michael A.
    Khagi, Simon
    Kaley, Thomas
    Melear, Jason
    Peereboom, David
    Rodriguez, Analiz
    Yankelevich, Maxim
    Nair, Suresh
    Puduvalli, Vinay
    Aldape, Kenneth
    Gao, Andrew
    Lopez-Janeiro, Alvaro
    de Andrea, Carlos
    Alonso, Marta
    Boutros, Paul
    Robbins, Joan
    Mason, Warren
    Sonaben, Adam
    Stupp, Roger
    Fueyo-Margareto, Juan
    Gomez-Manzano, Candelaria
    Lang, Frederick
    Zadeh, Gelareh
    NEURO-ONCOLOGY, 2023, 25
  • [34] LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.
    Kelly, Andrea True
    Ambady, Prakash
    Brown, Michael
    Butowski, Nicholas
    Cavaliere, Robert
    Curry, William
    Desjardins, Annick
    Franklin, Lisa
    Friedman, Henry
    Gromeier, Matthias
    Jackson, Leann
    Mixson, Lori
    Ong, Shirley
    Randazzo, Dina
    Sloan, Andrew
    Wen, Patrick
    Nichols., Garrett
    CANCER RESEARCH, 2021, 81 (13)
  • [35] LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.
    Sloan, Andrew E.
    Buerki, Robin Arthur
    Murphy, Christopher
    Kelly, Andrea True
    Ambady, Prakash
    Brown, Michael
    Butowski, Nicholas A.
    Cavaliere, Robert
    Curry, William T.
    Desjardins, Annick
    Franklin, Lisa
    Friedman, Henry S.
    Gromeier, Matthias
    Jackson, Leann
    Mixson, Lori
    Ong, Shirley S.
    Randazzo, Dina
    Wen, Patrick Y.
    Nichols, Garrett
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellitestable, refractory, metastatic colorectal cancer (mCRC)
    Friedrich, Tyler
    Blatchford, Patrick Jud
    Lentz, Robert William
    Davis, S. Lindsey
    Kim, Sunnie S.
    Leal, Alexis Diane
    Van De Voorde, Zoe
    Lee, Matthew R.
    Waring, Meredith
    Cull, Tiffany
    Martin, Anne
    Eckhardt, S. Gail
    Messersmith, Wells A.
    Lieu, Christopher Hanyoung
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [37] PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA
    Rauf, Yasmeen
    Schilero, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 33 - 33
  • [38] Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
    Ghiaseddin, Ashley
    Reardon, David A.
    Massey, Woody
    Mannerino, Alexandra
    Lipp, Eric S.
    Herndon, James E.
    McSherry, Frances
    Desjardins, Annick
    Randazzo, Dina M.
    Vlahovic, Gordana
    Friedman, Henry S.
    Peters, Katherine B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] PHASE II STUDY OF PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
    Lee, Eudocia
    Reardon, David
    Schiff, David
    Drappatz, Jan
    Muzikansky, Alona
    Hammond, Samantha
    Grimm, Sean
    Norden, Andrew
    Beroukhim, Rameen
    McCluskey, Christine
    Chi, Andrew
    Batchelor, Tracy
    Smith, Katrina
    Gaffey, Sarah
    Gerard, Mary
    Snodgras, Susan
    Raizer, Jeffrey
    Wen, Patrick
    NEURO-ONCOLOGY, 2013, 15 : 118 - 118
  • [40] Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study
    Fuereder, T.
    Minichsdorfer, C.
    Mittlboeck, M.
    Wagner, C.
    Oberndorfer, F.
    Mullauer, L.
    Aretin, M-B.
    Czerny, C.
    Schwarz-Nemec, U.
    ANNALS OF ONCOLOGY, 2020, 31 : S665 - S665
12345